Idiopathic pulmonary fibrosis treated with mesenchymal stem cells Allogenic derived from adipose tissue. Case report

Introduction: Idiopathic pulmonary fibrosis represents a pathology with a poor prognosis that has few high-cost therapeutic options, which is why stem cells represent a viable option that could improve the quality of life of these patients. Report: The case of a 75-year-old male patient with idiopathic pulmonary fibrosis and multiple comorbidities who managed to recover ambulation and reduce oxygen requirements thanks to the application of stem cells derived from the adipose tissue of one of his son. Conclusion: Stem cells are a valuable therapeutic alternative for patients with pulmonary fibrosis to promote the regeneration of tissues and reduce the inflammatory conditions of their pathology improving their quality of life.